17 Result(s)

Article

Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018

Yifei Liu, Martha Skup, Min Yang, Cynthia Z. Qi, Eric Q. Wu in Advances in Therapy (2022)

Article

Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018

To examine the prevalence rates of biosimilar discontinuation and switchback to the originator tumor necrosis factor alpha (TNF) inhibitors following non-medical switch (NMS) in patients.

Yifei Liu, Martha Skup, Min Yang, Cynthia Z. Qi, Eric Q. Wu in Advances in Therapy (2022)

Article

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States

Eosinophilic gastritis and eosinophilic enteritis (EoG/EoN) are associated with a substantial clinical burden. However, limited information is available regarding the economic burden of EoG/EoN. This study was...

Michael Woolley, Erin E. Cook, Fan Mu, Keith A. Betts, Emma Billmyer… in Advances in Therapy (2022)

Article

Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis

Hyperkalemia is often managed in the emergency department (ED) and it is important to understand how ED management and post-discharge outcomes vary by hyperkalemia severity. This study was conducted to charact...

Jill Davis, Rubeen Israni, Keith A. Betts, Fan Mu, Erin E. Cook… in Advances in Therapy (2022)

Article

Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia

Although hyperkalemia and metabolic acidosis often co-occur in patients with chronic kidney disease (CKD), the prevalence of metabolic acidosis among patients with CKD and hyperkalemia is understudied. Therefo...

Erin E. Cook, Jill Davis, Rubeen Israni, Fan Mu, Keith A. Betts… in Advances in Therapy (2021)

Article

Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8

Omar Dabbous, Benit Maru, Jeroen P. Jansen, Maria Lorenzi… in Advances in Therapy (2019)

Article

Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections

The new direct acting antiviral (DAA) therapies are able to effectively treat chronic hepatitis C (CHC). This study elicited the preferences of CHC patients for treatment attributes of new DAAs.

Tania M. Welzel, Min Yang, Gautam Sajeev, Yaozhu J. Chen… in Advances in Therapy (2019)

Article

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review

A systematic literature review was conducted to review and summarize the economic impact of non-medical switching (NMS) from biologic originators to their biosimilars (i.e., switching a patient’s medication fo...

Yifei Liu, Min Yang, Vishvas Garg, Eric Q. Wu, Jessie Wang… in Advances in Therapy (2019)

Article

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1

Infants with spinal muscular atrophy (SMA) type 1 typically face a decline in motor function and a severely shortened life expectancy. Clinical trials for SMA type 1 therapies, onasemnogene abeparvovec (AVXS-1...

Omar Dabbous, Benit Maru, Jeroen P. Jansen, Maria Lorenzi… in Advances in Therapy (2019)

Article

Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis

Patients with type 2 diabetes mellitus (T2DM) are clinically heterogeneous in terms of disease severity, treatment, and comorbidities, potentially resulting in differential diabetic nephropathy (DN) progressio...

Ruixuan Jiang, Ernest Law, Zhou Zhou, Hongbo Yang, Eric Q. Wu… in Diabetes Therapy (2018)

Article

Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

Diabetic nephropathy (DN) is a progressive kidney disease resulting as a complication of diabetes mellitus. This study evaluated the disease progression and economic burden of DN among commercially insured pat...

Zhou Zhou, Paresh Chaudhari, Hongbo Yang, Anna P. Fang, **g Zhao… in Diabetes Therapy (2017)

Article

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis

Invasive aspergillosis (IA) is associated with a significant clinical and economic burden. The phase III SECURE trial demonstrated non-inferiority in clinical efficacy between isavuconazole and voriconazole. N...

Rachel Harrington, Edward Lee, Hongbo Yang, ** Wei, Andrew Messali… in Advances in Therapy (2017)

Article

Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study

A majority of patients with diabetes do not have levels of glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) under control, either individually or in combination. The objective was to...

Lizheng Shi, **n Ye, Mei Lu, Eric Q. Wu, Hari Sharma, Darren Thomason… in Diabetes Therapy (2015)

Article

Cost Per Responder Associated with Biologic Therapies for Crohn’s Disease, Psoriasis, and Rheumatoid Arthritis

Biologic therapies have demonstrated efficacy and safety in several chronic systemic disorders. The authors indirectly compared response rates and costs per responder associated with biologic treatments for mo...

Yifei Liu, Eric Q. Wu, Arielle G. Bensimon, Chun-Po Steve Fan… in Advances in Therapy (2012)